6/17/2019  4:38:06 PM Chg. +1.45 Volume Bid- Ask4:44:53 PM Market Capitalization Dividend Y. P/E Ratio
324.51USD +0.45% 798
Turnover: 258,297.35
-Bid Size: - 324.61Ask Size: 100 15.99 bill.USD 0.02% 42.35

Business description

The Cooper Companies, Inc. ("Cooper") is a global medical device company publicly traded on the NYSE Euronext (NYSE:COO). Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical focuses on supplying women's health clinicians with market leading products and treatment options to improve the delivery of healthcare to women. Headquartered in Pleasanton, CA, Cooper has approximately 10,000 employees with products sold in over 100 countries.

Management board & Supervisory board

Albert G. White, III
Management board
Brian Andrews, Agostino Ricupati, Daniel G. McBride, Holly Sheffield, Randy Golden, Robert D. Auerbach
Supervisory board
A. Thomas Bender, Albert G. White, III, Allan E. Rubenstein, Colleen E. Jay, Gary S. Petersmeyer, Jody S. Lindell, Michael H. Kalkstein, Robert S. Weiss, William A. Kozy

Company data

Name: Cooper Companies Inc.
Address: 6140 Stoneridge Mall Road, Suite 590,Pleasanton, CA 94588, USA
Phone: +1-925-460-3600
Fax: -
E-mail: -
Internet: www.coopercos.com
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 10/31
Free Float: 54.90%
IPO date: -

Investor relations

Name: Kim Duncan
IR phone: +1-925-460-3663
IR-Fax: -
IR e-mail: ir@cooperco.com

Main Shareholders

T. Rowe Price Associates, Inc.
The Vanguard Group, Inc.
BlackRock, Inc.
Massachusetts Financial Services Company
Generation Investment Management LLP
State Street Corporation